---
figid: PMC5727250__BPH-174-4701-g003
figtitle: Possible Wnt pathway‐related therapeutic targets in CLL
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC5727250
filename: BPH-174-4701-g003.jpg
figlink: /pmc/articles/PMC5727250/figure/bph13949-fig-0003/
number: F3
caption: Possible Wnt pathway‐related therapeutic targets in CLL. Scheme summarizes
  the candidate therapeutic targets in CLL and their position in the Wnt pathway.
  Examples of compounds tested in the preclinical or early phase clinical trials are
  shown. See text for details.
papertitle: Wnt signalling pathways in chronic lymphocytic leukaemia and B‐cell lymphomas.
reftext: Pavlína Janovská, et al. Br J Pharmacol. 2017 Dec;174(24):4701-4715.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.959849
figid_alias: PMC5727250__F3
figtype: Figure
redirect_from: /figures/PMC5727250__F3
ndex: 7583d3fc-deb2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5727250__BPH-174-4701-g003.html
  '@type': Dataset
  description: Possible Wnt pathway‐related therapeutic targets in CLL. Scheme summarizes
    the candidate therapeutic targets in CLL and their position in the Wnt pathway.
    Examples of compounds tested in the preclinical or early phase clinical trials
    are shown. See text for details.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - CTNNB1
  - LEF1
  - ROR1
  - RORA
  - ctnnb1
  - lef1
  - ror1
  - PF-670462
  - PF-4800567
---
